期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

蒽环类耐药性乳腺癌的治疗策略 被引量：85

原文传递
导出
摘要 蒽环类药物是治疗乳腺癌最有效的药物之一。含蒽环类药物的联合方案（如CAF、CEF）是乳腺癌术后辅助治疗或复发转移性乳腺癌的一线方案。但曾用过蒽环类药物的乳腺癌患者，二线方案的疗效较差，治疗的难度加大，这主要是由于癌细胞对蒽环类药物产生了耐药性。
作者 徐兵河
机构地区 中国医学科学院中国协和医科大学肿瘤研究所肿瘤医院内科
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2007年第4期241-244,共4页 Chinese Journal of Oncology
关键词 蒽环类药 乳腺肿瘤 耐药性 治疗 Anthracyclines Breast neoplasms Drug resistance Treatment
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献15

  • 1袁芃，徐兵河．乳腺癌的耐药问题．见：徐兵河主编．乳腺癌．北京：北京大学医学出版社，2005．105-120．
  • 2Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in multidrug resistant human lung cancer cell line. Science, 1992, 258: 1650-1654.
  • 3Scheper R J, Broxterman H J, Scheffer GL, et al. Overexpression of a M (r) 110 000 vesicular protein in non-P-glycoprotein-meidiated multidrug resistance. Cancer Res, 1993, 53: 1475-1479.
  • 4Xu BH, Singh SV. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mltomycin C analogues BMY 25282 and BMY 25067. Cancer Res, 1992, 52 : 6666-6670.
  • 5Xu BH, Gupta V, Singh SV. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C. Int J Cancer, 1994, 58 : 686-692.
  • 6Maiche AG, Jekumen AP, Kaleva-Kerola J, et al. High response rate with a lower dose of paclitaxel in combination with cispaltin in heavily pretreated patients with advanced breast carcinoma. Cancer, 2000, 88: 1863-1868.
  • 7Airoldi M, Cattel L, Pedani F, et al. Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycine resistant/relapsed metastatic breast cancer. Acta Oncol, 2003, 42: 186-194.
  • 8O'shaughnessv J, Miles D, Vakelja S, et al. Superior survival with capecitahlne plus docetaxel comhinati.on therapy in anthracycline- pretreated patients with advanced breast cancer: phase Ⅲ trial results. J Clin Oncol, 2002, 20:2812-23.
  • 9袁芃,徐兵河,李青,张频,赵龙妹.去甲长春花碱为主方案治疗蒽环类药物耐药性晚期乳腺癌的疗效[J].中国肿瘤临床,2001,28(8):602-604. 被引量：15
  • 10徐兵河,袁芃,李青,张频,赵龙妹,周际昌.去甲长春花碱联合顺铂治疗晚期乳腺癌的临床疗效[J].中华肿瘤杂志,2001,23(6):521-522. 被引量：50

二级参考文献27

  • 1[1]Heinemann V. Gemcitabine plus cisplatin for the treatment of metastatic breast cancer[ J]. Clin Breast Cancer,2002,3 (Suppl 1 ): S24-S29.
  • 2[2]Seidman AD. Gemcitabine as single-agent therapy in the management of advanced breast cancer [ J ]. Oncology, 2001,15(2) (Suppl 3): 11-14.
  • 3[3]Jurga L,Misurova E, Kovac V, et al. The role of cisplatin in chemotherapy of advanced breast cancer[J]. Neoplasma, 1994,41 ( 6 ) :347-352.
  • 4[4]Carmichael J, Walling J. Advanced breast cancer:investigational role of gemcitabine[ J]. Eur J Cancer, 1997,33( Suppl 1 ): S27-S31.
  • 5[5]Pegram MD, Lipton A, Hayes DF, et al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment [ J ]. J Clin Oncol, 1998, 16(8) :2659-2671.
  • 6[6]Ray-Coquard Ⅰ, Biron P, Bachelot T, et al. Vinorelbine and cisplatin ( CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline-and/or paclitaxelcontaining regimens[ J]. Cancer, 1998 ,82 ( 1 ): 134-140.
  • 7[7]Vassilomanolakis M, Koumakis G, Barbounis V, et al.Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines [ J ]. Ann Oncol, 2000,11(5) :1155-1160.
  • 8[8]Moorsel CJ, Veerman G, Bergman AM, et al. Combination chemotherapy studies with gemcitabine[ J]. Semin Oncol, 1997,2,4(2): S7-S23.
  • 9[9]Nagourney RA, Evans SS, Makalinao AJ, et al. Gemcitabine activity in primary cultures of human caner ( Abstract 2161 )[J]. Proc Am Assoc Cancer Res, 1996,37: 318.
  • 10[1]Blum JL,Dieras V,Lo Russo PM,et al.Multicenter,phase Ⅱ study of capecitabine in taxane-pretreated metastatic breast carcinoma.Cancer,2001,92:1759

共引文献187

同被引文献559

引证文献85

二级引证文献313

中华肿瘤杂志
2007年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部